← Evidence map

ArticleCancer discovery2021

Mobocertinib (TAK-788): A Targeted Inhibitor of

Francois Gonzalvez et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

104 papers cite itlatest 60 shown

2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 33632773